PRME: Utang marang Ekuitas primemedicine.com

Tandha merek Prime Medicine Bio (PRME)

Prime Medicine, Inc. (PRME) is creating a unique DNA editing ecosystem with high capitalization potential. The debt-to-equity capital structure on the GURU.Markets chart confirms financial stability, with the metric holding around 2.84. Technical processes are partially automated via robotics but require physician oversight. Aggressive expert hiring and stock options ensure the retention of the core R&D team.

PRME: Total Utang marang Modal Prime Medicine 28.04.2023 - 01.11.2026

Prime Medicine Bio - rincian analitis lan metrik utama (PRME)

- rega saham lan konsensus proyeksi valuasi:
Rega saham Prime Medicine|PRME - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Nilai pasar Prime Medicine|PRME - Nilai Bisnis
- rincian nilai buku perusahaan:
Nilai Buku saben Saham Prime Medicine|PRME - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku primemedicine.com|PRME - Nilai Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas Prime Medicine, Inc.|PRME - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Prime Medicine, Inc.|PRME - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Prime Medicine|PRME - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Prime Medicine|Indikator likuiditas cepet primemedicine.com
- informasi bathi lan kelipatan valuasi:
PRME - Bathi pungkasan
Analisis wiwitan perusahaan:PRME, Prime Medicine
Barang utama Prime Medicine Bio

Prime Medicine, Inc. (PRME) minimizes capital expenditures by outsourcing early-stage molecule testing to external CRO contractors. This ratio measures the proportion of borrowed funds within the financing structure relative to equity. It is critical for investors to monitor this balance to assess bankruptcy risk and financial autonomy. Excessive leverage may limit the development flexibility of the biotech startup. An analysis of the total debt-to-equity ratio confirms the company's current margin of safety.

Analisis perusahaan pesaing

TEM (tempus.com) - Total Utang marang Modal|Rasio Utang marang Ekuitas QGEN (Qiagen NV)|Utang marang Ekuitas Ionis Pharma (IONS)|Repligen Inc. - Rasio Utang marang Ekuitas|Total Utang marang Modal RNA (Avidity Biosciences)|Total Utang marang Modal crisprtx.com CRSP|WGS - Utang marang Ekuitas|Utang Agregat marang Ekuitas RARE|Beam Therapeutics Corp (BEAM) - Utang marang Ekuitas|Sarepta Corp - Rasio Kabeh Utang marang Dana Pribadi|TWST (Twist Bioscience) - Total Utang marang Modal|10xgenomics.com (TXG) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Intellia Therapeutics, Inc. (NTLA)|Rasio Total Utang marang Ekuitas Stoke Therapeutics Inc STOK|Total Utang marang Modal BLFS (BioLife Corp)|Wave Pharma (WVE) - Utang marang Modal|MAZE: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SION (sionnatx.com)|Taysha Gene Therapies, Inc. (TSHA) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas uniQure NV|MGTX (MeiraGTx PLC) - Total Utang marang Modal|Utang marang Modal REGENXBIO Corp RGNX|Total Utang marang Modal SLDB|ocugen.com - Rasio Utang marang Ekuitas|Total Utang marang Modal PACB (PacBio)|Koefisien Total Utang marang Modal Benitec Biopharma Inc (BNTC)|Design Pharma - Total Utang marang Modal|Rocket Corp (RCKT) - Rasio Total Utang marang Ekuitas|FDMT: Total Utang marang Modal|LXEO - Koefisien Total Utang marang Modal|Utang marang Ekuitas Korro Bio Inc.|Rasio Utang marang Ekuitas EDIT (Editas Medicine Inc)|Total Utang marang Modal SLN|PRQR - Utang marang Modal|Codexis - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SGMO|Nautilus Biotechnology Inc - Total Utang marang Modal|Koefisien Total Utang marang Modal Metagenomi Inc. MGX|Precision BioSciences, Inc. (DTIL) - Utang marang Ekuitas|Rasio Utang marang Ekuitas GBIO|BOLD (Boundless Bio, Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Exicure Corp (XCUR)|Rasio Total Utang marang Ekuitas IMNN (Imunon, Inc.)|Koefisien Total Utang marang Modal phiopharma.com|Utang marang Ekuitas Mustang Bio MBIO|RNAZ (TransCode Therapeutics Inc.) - Utang Agregat marang Ekuitas|BNGO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi APDN (adnas.com)|bluebird bio (BLUE) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas ImmunoPrecise Antibodies Ltd.|OMGA (Omega) - Total Utang marang Modal|Utang marang Modal Singular Genomics Corp OMIC|Total Utang marang Modal RGLS|syros.com - Rasio Utang marang Ekuitas|Utang marang Ekuitas Telesis Bio TBIO|TCON: Rasio Utang marang Ekuitas|Unity Bio - Total Utang marang Modal